{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:56Z","timestamp":1761630416981},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3446,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/sj.ki.5001597","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T04:08:43Z","timestamp":1151640523000},"page":"S16-S21","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S102","title":["Influence of parathyroid mass on the regulation of PTH secretion"],"prefix":"10.1016","volume":"70","author":[{"given":"E.","family":"Lewin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Olgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001597_bb0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: a disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0020","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1210\/endo.137.11.8895317","article-title":"Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery","volume":"137","author":"Wang","year":"1996","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001597_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00041552-199607000-00008","article-title":"Molecular genetics of hyperparathyroid disease","volume":"5","author":"Tominaga","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 80","key":"10.1038\/sj.ki.5001597_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1523-1755.61.s80.26.x","article-title":"Pathogenesis of refractory secondary hyperparathyroidism","volume":"61","author":"Rodriguez","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0035","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1046\/j.1523-1755.2001.00986.x","article-title":"Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism","volume":"60","author":"Valimaki","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1523-1755.1999.00230.x","article-title":"Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia","volume":"55","author":"Matsushita","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0045","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001597_bb0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1523-1755.2001.059003855.x","article-title":"p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth","volume":"59","author":"Dusso","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0055","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0060","first-page":"5","article-title":"Pathogenesis of parathyroid hyperplasia in renal failure","volume":"18","author":"Cozzolino","year":"2005","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0065","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00167.2005","article-title":"A Critical role for enhanced-TGF{alpha} and EGFR Expression in the initiation of parathyroid hyperplasia in experimental kidney disease","volume":"289","author":"Cozzolino","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5001597_bb0070","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/oxfordjournals.ndt.a027131","article-title":"De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism","volume":"11","author":"Gogusev","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001597_bb0075","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1046\/j.1523-1755.2003.00331.x","article-title":"Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender","volume":"64","author":"Almaden","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1523-1755.2000.00863.x","article-title":"Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism","volume":"57","author":"Zhang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0085","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001597_bb0090","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001597_bb0095","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000188591","article-title":"Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus","volume":"70","author":"Yi","year":"1995","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001597_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0110","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jn\/107.10.1918","article-title":"Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol","volume":"107","author":"Henry","year":"1977","journal-title":"J Nutr"},{"key":"10.1038\/sj.ki.5001597_bb0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM199008093230617","article-title":"Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis","volume":"323","author":"Fukagawa","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001597_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000188261","article-title":"Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients","volume":"68","author":"Fukagawa","year":"1994","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001597_bb0125","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","article-title":"Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism","volume":"57","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0135","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/01.ASN.0000024439.38838.03","article-title":"Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation","volume":"13","author":"Lewin","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ki.1997.448","article-title":"Reversibility of experimental secondary hyperparathyroidism","volume":"52","author":"Lewin","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0145","first-page":"18","article-title":"A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients","volume":"51","author":"Chertow","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000185744","article-title":"Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis","volume":"53","author":"Brandi","year":"1989","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001597_bb0160","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0165","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1053\/ajkd.2001.27425","article-title":"Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients","volume":"38","author":"Akizawa","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001597_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/ajkd.1998.v32.pm9708607","article-title":"Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism","volume":"32","author":"Akiba","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001597_bb0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1038\/sj.ki.5001597_bb0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000188833","article-title":"Successful treatment of secondary hyperparathyroidism in hemodialysis patients with oral pulse 1-alpha-hydroxy-cholecalciferol therapy","volume":"72","author":"Rapoport","year":"1996","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001597_bb0185","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001597_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium \u00d7 phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0195","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001597_bb0200","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5414\/CNP61253","article-title":"PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy","volume":"61","author":"Schindler","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0210","first-page":"3923","article-title":"Accumulation of a non-(1\u201384) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001597_bb0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1470123","article-title":"Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays","volume":"147","author":"Nguyen-Yamamoto","year":"2002","journal-title":"Eur.J Endocrinol"},{"key":"10.1038\/sj.ki.5001597_bb0220","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1\u201384) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"key":"10.1038\/sj.ki.5001597_bb0225","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(97)90129-3","article-title":"No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients","volume":"29","author":"Dumoulin","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001597_bb0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ndt\/13.2.434","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001597_bb0235","first-page":"113","article-title":"Parathyroid function after successful renal transplantation","volume":"35","author":"Botha","year":"1997","journal-title":"S Afr J Surg"},{"key":"10.1038\/sj.ki.5001597_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s002689900446","article-title":"Prospective study of calcium homeostasis after renal transplantation","volume":"22","author":"Claesson","year":"1998","journal-title":"World J Surg"},{"key":"10.1038\/sj.ki.5001597_bb0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<97::AID-SSU5>3.0.CO;2-X","article-title":"Renal transplantation and secondary hyperparathyroidism","volume":"13","author":"Uchida","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1038\/sj.ki.5001597_bb0250","first-page":"1049","article-title":"Tertiary hyperparathyroidism after renal transplantation: operative indications","volume":"106","author":"D'Alessandro","year":"1989","journal-title":"Surgery"},{"key":"10.1038\/sj.ki.5001597_bb0255","first-page":"92","article-title":"Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland","volume":"8","author":"Parfitt","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"10.1038\/sj.ki.5001597_bb0260","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/ndt\/12.11.2393","article-title":"Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome","volume":"12","author":"Schmid","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001597_bb0265","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s002680010230","article-title":"Persistent hyperparathyroidism requiring surgical treatment after kidney transplantation","volume":"24","author":"Kinnaert","year":"2000","journal-title":"World J Surg"},{"key":"10.1038\/sj.ki.5001597_bb0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1681\/ASN.V132551","article-title":"Calcium metabolism and skeletal problems after transplantation","volume":"13","author":"Torres","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.1982.227","article-title":"Parathyroid function in persistent hyperparathyroidism: relationship to gland size","volume":"22","author":"McCarron","year":"1982","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00041552-200307000-00004","article-title":"Involution of the parathyroid glands after renal transplantation","volume":"12","author":"Lewin","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5001597_bb0290","first-page":"S42","article-title":"Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure","volume":"44","author":"Tominaga","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1755.2000.00142.x","article-title":"PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands","volume":"58","author":"Lewin","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1523-1755.2003.00056.x","article-title":"Autoregulation in the parathyroid glands by PTH\/PTHrP receptor ligands in normal and uremic rats","volume":"64","author":"Lewin","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001597_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/EP:15:1:29","article-title":"Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland","volume":"15","author":"Bell","year":"2004","journal-title":"Endocr Pathol"},{"key":"10.1038\/sj.ki.5001597_bb0310","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1681\/ASN.V1271468","article-title":"Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells","volume":"12","author":"Finch","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001597_bb0315","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0046-8177(84)80306-8","article-title":"Functioning oxyphil cell adenoma of the parathyroid gland: a clinicopathologic study of ten patients with hyperparathyroidism","volume":"15","author":"Bedetti","year":"1984","journal-title":"Hum Pathol"},{"key":"10.1038\/sj.ki.5001597_bb0320","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ajcp\/78.5.681","article-title":"Functioning oxyphil cell adenomas of parathyroid gland: immunoperoxidase evidence of hormonal activity in oxyphil cells","volume":"78","author":"Ordonez","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/sj.ki.5001597_bb0325","first-page":"861","article-title":"Co-secretion of parathyroid hormone and parathyroid-hormone-related protein via a regulated pathway in human parathyroid adenoma cells","volume":"150","author":"Matsushita","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5001597_bb0330","first-page":"184","article-title":"Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation","volume":"51","author":"Lewin","year":"2004","journal-title":"Dan Med Bull"},{"key":"10.1038\/sj.ki.5001597_bb0335","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1523-1755.2002.00265.x","article-title":"Hyperplasia of the parathyroid gland without secondary hyperparathyroidism","volume":"61","author":"Takahashi","year":"2002","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:48:24Z","timestamp":1627519704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815518206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":66,"alternative-id":["S0085253815518206"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001597","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}